enter here
Ketamine for Older Adults Pilot
About the study
NCT Trial Number
NCT04504175
The drug being studied
Ketamine
Sponsored by
Washington University School of Medicine
Trial Start Date
Sep-20
About the participants
Age seeking
65 Years and older
gender
All
Primary condition of volunteers accepted
Depression
Accepts healthy volunteers?
Yes
To assess the safety and feasibility of intravenous (IV) ketamine in older adults with Treatment-Resistant Depression (TRD)
Locations
United States, California
UCLA Late-Life Mood, Stress, and Wellness Research Program
Los Angeles, California, United States, 90095
Contact: Yesenia Aguilar Faustino
yafaustino@mednet.ucla.edu
310-825-2065
Contact: Raquel Hernandez Sotomayor
RHernandezSotomayor@mednet.ucla.edu
310-267-5264
United States, Missouri
Washington University School of Medicine Healthy Mind Lab
Saint Louis, Missouri, United States, 63110
Contact: Emily Lenard, MSW
lenarde@wustl.edu
314-747-5706
Contact: Julie Schweiger, CCRC
schweigj@wustl.edu
314-362-3153
United States, New York
Columbia University Adult and Late Life Depression Clinic
New York, New York, United States, 10032
Contact: Carolina Montes Garcia
carolina.montes@nyspi.columbia.edu
646-774-8648
Contact: Esteban Ceballos
esteban.ceballos@nyspi.columbia.edu
646-774-8670
United States, Pennsylvania
UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program
Pittsburgh, Pennsylvania, United States, 15213
Contact: Sunita Chickering
412-246-6021
chickeringsn@upmc.edu
Contact: Joelle Kincman, PhD
412-246-6012
scanjm2@upmc.edu
Canada, Ontario
University Health Network
Toronto, Ontario, Canada, M6J-1H4
Contact: Athina Perivolaris, RN, MN
416-535-8501 ext 32897
athina.perivolaris@camh.ca
Contact: Nisha Patel
Nisha.Patel@uhnresearch.ca